Marrone Bio Innovations Hires New Marketing Leadership

DAVIS, Calif., Dec. 16, 2015 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI), (NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, today announced that Nancy Hood has joined the company as its Vice President of Marketing. In this role, Nancy will be responsible for the strategic marketing of MBI’s portfolio of products to growers and distributors of agriculture products.

Ms. Hood is a veteran of the agriculture industry with more than 20 years of strategic marketing experience. Nancy joins MBI from Silverlake Consulting, a boutique marketing firm she founded in 2012, where she conducted marketing projects for the largest biopesticide company (Valent Biosciences) in the industry.

“We are very pleased to have Nancy join MBI. She is an experienced marketing executive with a proven track record of leading marketing and communication strategies for both biological and conventional crop protection products, and other ag-related firms,” said Pam Marrone, Chief Executive Officer of MBI. “Nancy will play a pivotal role in driving our business forward as we continue our efforts to implement our growth strategy, execute on our plans to provide effective and environmentally responsible solutions to our customers, and sharpen our focus on driving value to our shareholders.”

Nancy Hood hails from six generation of farmers and ranchers in the Texas Panhandle. She has extensive experience in production agriculture and livestock management. Professionally, she has spent more than 20 years working to help American agriculture meet global standards for production, sustainability, transparency and social responsibility while marketing seeds, equipment and crop protection products. She has worked in virtually every state in the U.S., leading initiatives in corn, cotton, soybeans, fruits, vegetables, nuts, wheat, canola, milo and numerous specialty crops.

Prior to founding Silverlake Consulting, Nancy held senior positions at multiple agriculture, marketing and communications companies, including ArborGen, The Integer Group, GCI Group Atlanta, Sawyer Riley Compton and Gibbs & Soell. She is a life member of American AgriWomen, and has held leadership positions in several agriculture and marketing associations, such as the National Agricultural Marketing Association, Livestock Publications Council and American Agricultural Editors Association. Nancy is a graduate of Texas Tech University where she received her B.A. in English with a minor in Agricultural Economics.

About Marrone Bio Innovations

Smart. Natural. Solutions.

Marrone Bio Innovations, Inc. (NASDAQ:MBII) aims to lead the movement to a more sustainable world through the discovery, development and promotion of biological products for pest management and plant health. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health and increasing crop yields. We have three products for agriculture on the market, a proprietary discovery process, a rapid development platform and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit

Forward Looking Statements

Portions of this press release may constitute “forward-looking statements,” and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the “safe-harbor” protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaims any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this filing include those regarding implementing our growth strategy, execution of our plans and driving value to shareholders. Such forward-looking statements are based on information available to us as of the date of this release and involve a number of risks and uncertainties, some beyond our control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include inability to obtain regulatory approval for or commercialize our products, or to comply with ongoing and changing regulatory requirements, which could delay or prevent sales, failure of customers to adopt our products and competition in the markets for our products. Additional information that could lead to material changes in our performance is contained in our filings with the Securities and Exchange Commission.

Media Contact: Cory Ziskind ICR 646-277-1232

Source:Marrone Bio Innovations